无容量
医学
围手术期
新辅助治疗
肺癌
佐剂
化疗
肿瘤科
内科学
外科
癌症
免疫疗法
乳腺癌
作者
Tina Cascone,Mark M. Awad,Jonathan Spicer,Jie He,Shun Lü,Boris Sepesi,Fumihiro Tanaka,Janis M. Taube,Robin Cornelissen,Libor Havel,Nina Karaseva,Jarosław Kużdżał,Luboš Petruželka,Lin Wu,Jean-Louis Pujol,Hiroyuki Ito,Tudor‐Eliade Ciuleanu,Ludmila de Oliveira Muniz Koch,Annelies Janssens,Aurelia Alexandru
标识
DOI：10.1056/nejmoa2311926
摘要
Standard treatment with neoadjuvant nivolumab plus chemotherapy significantly improves outcomes in patients with resectable non-small-cell lung cancer (NSCLC). Perioperative treatment (i.e., neoadjuvant therapy followed by surgery and adjuvant therapy) with nivolumab may further improve clinical outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI
cdercder
bc
归尘
冰魂
昏睡的蟠桃
pluto
顺心香菇
Auston_zhong
jenningseastera
1111
乐乐
back you up
我是站长才怪
平常的毛豆
科研小民工
斯寜
糟糕的铁锤
勤劳的忆寒
nvatk16
默默地读文献
皖公网安备34019202002308
